Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Avadel Pharmaceuticals Plc, Medical Devices Deals, 2011 to YTD 2017 11
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Flamel Technologies Enters Into Product Partnership Agreement With Pharma Company 14
Flamel Technologies Enters Into Co-Development Agreement With Digna Biotech 15
Theralpha Enters Into Co-Development Agreement With Flamel Technologies 17
Merger 18
Flamel Technologies Merges with Avadel Pharma 18
Licensing Agreements 19
Avadel Pharma to Enter into Licensing Agreement with Serenity Pharma for Noctiva 19
Perrigo Enters into Licensing Agreement with Flamel Ireland 21
Tris Pharma And FSC Labs Enter Into Licensing Agreement For Karbinal ER 22
Eagle Pharma Enters Into Licensing Agreement With Flamel Technologies 23
Flamel Technologies Enters Into Licensing Agreement For Micropump Platform 24
Flamel Technologies Enters Into Licensing Agreement For Micropump 25
Equity Offering 26
Flamel to Raise USD13.1 Million in Private Placement of Shares 26
Flamel Technologies Completes Public Offering Of Shares For US$121 Million 27
Debt Offering 29
Flamel Technologies Completes Private Placement Of Notes Due 2017 For US$15 Million 29
Asset Transactions 30
Aytu BioScience Acquires Rights to Primsol from FSC Labs for USD1.8 Million 30
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 31
Acquisition 33
Flamel Technologies Acquires FSC Holdings 33
Flamel Technologies Acquires Eclat Pharma For US$12 Million 35
Avadel Pharmaceuticals Plc – Key Competitors 37
Avadel Pharmaceuticals Plc – Key Employees 38
Avadel Pharmaceuticals Plc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 41
Financial Announcements 41
Nov 08, 2017: Avadel Pharmaceuticals Reports Third Quarter 2017 Results 41
Aug 08, 2017: Avadel Pharmaceuticals Reports Second Quarter 2017 Results 43
May 09, 2017: Avadel Pharmaceuticals Reports First Quarter 2017 Results 45
Mar 07, 2017: Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results 46
Nov 07, 2016: Flamel Technologies Reports Third Quarter 2016 Results 48
Aug 08, 2016: Flamel Technologies Reports Second Quarter 2016 Results 49
May 09, 2016: Flamel Technologies Reports First Quarter 2016 Results 51
Mar 10, 2016: Flamel Technologies Reports Fourth Quarter and Full Year 2015 Results 52
Corporate Communications 54
Mar 30, 2017: Avadel Pharmaceuticals Announces Planned Reduction of French Workforce 54
Jan 03, 2017: Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Commercial Officer 55
Clinical Trials 56
May 17, 2017: Avadel Pharmaceuticals Supports the Narcolepsy Network’s 5th Annual DREAM BIG Walk 56
Dec 16, 2016: Flamel Technologies Doses First Patient in REST-ON Phase III Trial of FT218 for Excessive Daytime Sleepiness & Cataplexy 57
Oct 06, 2016: Flamel Technologies Reaches Agreement With FDA on Protocol for Phase III Pivotal Trial of FT218 58
Mar 31, 2016: Flamel Technologies Files Special Protocol Assessment for Once Nightly Sodium Oxybate 59
Other Significant Developments 60
Jan 05, 2017: Avadel Pharmaceuticals Provides 2017 Guidance and Business Update 60
Jan 08, 2016: Flamel Technologies Provides Update on Corporate Progress 62
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Avadel Pharmaceuticals Plc, Deals By Therapy Area, 2011 to YTD 2017 9
Avadel Pharmaceuticals Plc, Medical Devices Deals, 2011 to YTD 2017 11
Avadel Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Flamel Technologies Enters Into Product Partnership Agreement With Pharma Company 14
Flamel Technologies Enters Into Co-Development Agreement With Digna Biotech 15
Theralpha Enters Into Co-Development Agreement With Flamel Technologies 17
Flamel Technologies Merges with Avadel Pharma 18
Avadel Pharma to Enter into Licensing Agreement with Serenity Pharma for Noctiva 19
Perrigo Enters into Licensing Agreement with Flamel Ireland 21
Tris Pharma And FSC Labs Enter Into Licensing Agreement For Karbinal ER 22
Eagle Pharma Enters Into Licensing Agreement With Flamel Technologies 23
Flamel Technologies Enters Into Licensing Agreement For Micropump Platform 24
Flamel Technologies Enters Into Licensing Agreement For Micropump 25
Flamel to Raise USD13.1 Million in Private Placement of Shares 26
Flamel Technologies Completes Public Offering Of Shares For US$121 Million 27
Flamel Technologies Completes Private Placement Of Notes Due 2017 For US$15 Million 29
Aytu BioScience Acquires Rights to Primsol from FSC Labs for USD1.8 Million 30
Recipharm Acquires Development and Manufacturing Facility from Flamel for USD13.2 Million 31
Flamel Technologies Acquires FSC Holdings 33
Flamel Technologies Acquires Eclat Pharma For US$12 Million 35
Avadel Pharmaceuticals Plc, Key Competitors 37
Avadel Pharmaceuticals Plc, Key Employees 38
Avadel Pharmaceuticals Plc, Subsidiaries 39